AstraZeneca CEO says UK business climate deters investment

  • 📰 Reuters
  • ⏱ Reading Time:
  • 12 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 8%
  • Publisher: 97%

Nederland Nieuws Nieuws

Nederland Laatste Nieuws,Nederland Headlines

Britain's business climate is deterring biopharma companies from investing in the country, AstraZeneca chief Pascal Soriot said on Thursday, highlighting his company's decision to shift plans for a new manufacturing plant to Ireland.

The British drugmaker seeks to offset declining sales of COVID-19 medicines with its cancer, metabolic and rare disease drugs and Soriot said it is on track to deliverHe highlighted AstraZeneca's recent decision to build a manufacturing facility in Ireland instead of the UK as evidence of Britain becoming less attractive for drugmakers.

The VPAS began in 2019 to help make drugs more affordable for the national health system , by returning a proportion of funds based on the sales of branded prescription medicines when a maximum sales growth rate is exceeded.

Wij hebben dit nieuws samengevat zodat u het snel kunt lezen. Bent u geïnteresseerd in het nieuws, dan kunt u hier de volledige tekst lezen. Lees verder:

 /  🏆 2. in NL
 

Bedankt voor uw reactie. Uw reactie wordt na beoordeling gepubliceerd.

Jim_Cornelius Where's the 'tidal wave' BorisJohnson ?

Brexit benefits

Time to roll out the official blaming of the remainer, metropolitan elite, left wing economic establishment, anti growth coalition, woke lefties who don't believe in the BREXIT fairy.

Nederland Laatste Nieuws, Nederland Headlines